Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats

The present study evaluated the effects of long-term treatment with the endothelin A (ETA) receptor antagonist darusentan (LU135252) on blood pressure (BP) and vascular target-organ damage in spontaneously type 2 diabetic Goto-Kakizaki (GK) rats. BP was monitored by radiotelemetry in untreated and d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Witte, Klaus (VerfasserIn) , Reitenbach, Ina (VerfasserIn) , Stolpe, Kerstin (VerfasserIn) , Schilling, Lothar (VerfasserIn) , Kirchengast, Michael (VerfasserIn) , Lemmer, Björn (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2003
In: Journal of cardiovascular pharmacology
Year: 2003, Jahrgang: 41, Heft: 6, Pages: 890-896
ISSN:1533-4023
DOI:10.1097/00005344-200306000-00009
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/00005344-200306000-00009
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/cardiovascularpharm/Fulltext/2003/06000/Effects_of_the_Endothelin_A_Receptor_Antagonist.9.aspx
Volltext
Verfasserangaben:Klaus Witte, Ina Reitenbach, Kerstin Stolpe, Lothar Schilling, Michael Kirchengast, and Björn Lemmer

MARC

LEADER 00000caa a2200000 c 4500
001 1796774545
003 DE-627
005 20230428010645.0
007 cr uuu---uuuuu
008 220328s2003 xx |||||o 00| ||eng c
024 7 |a 10.1097/00005344-200306000-00009  |2 doi 
035 |a (DE-627)1796774545 
035 |a (DE-599)KXP1796774545 
035 |a (OCoLC)1341458163 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Witte, Klaus  |d 1962-  |e VerfasserIn  |0 (DE-588)1104517922  |0 (DE-627)861919793  |0 (DE-576)471123668  |4 aut 
245 1 0 |a Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats  |c Klaus Witte, Ina Reitenbach, Kerstin Stolpe, Lothar Schilling, Michael Kirchengast, and Björn Lemmer 
264 1 |c June 2003 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.03.2022 
520 |a The present study evaluated the effects of long-term treatment with the endothelin A (ETA) receptor antagonist darusentan (LU135252) on blood pressure (BP) and vascular target-organ damage in spontaneously type 2 diabetic Goto-Kakizaki (GK) rats. BP was monitored by radiotelemetry in untreated and darusentan-treated GK rats from 10-24 weeks of age. Relaxation of mesenteric artery segments by acetylcholine (ACh) and sodium nitroprusside (SNP) was measured to assess endothelium-dependent and -independent vasorelaxation. Aortic soluble guanylyl cyclase (sGC) activity was studied in vitro after stimulation by the nitric oxide (NO) donor diethylamine-NONOate. Untreated GKs were mildly hypertensive and showed a blunted vascular relaxation by ACh and SNP and a reduction in NO-stimulated sGC activity in comparison with Wistar control rats. Darusentan led to a small but sustained reduction in 24-h BP but did not restore the endothelium-dependent vasorelaxation nor the NO-stimulated cGMP formation in GK rats. The present findings suggest that an activated endothelin pathway may contribute to elevated BP but is not involved in vascular dysfunction in this animal model of type II diabetes. 
700 1 |a Reitenbach, Ina  |e VerfasserIn  |4 aut 
700 1 |a Stolpe, Kerstin  |e VerfasserIn  |4 aut 
700 1 |a Schilling, Lothar  |d 1954-  |e VerfasserIn  |0 (DE-588)1028374690  |0 (DE-627)730623521  |0 (DE-576)375909893  |4 aut 
700 1 |a Kirchengast, Michael  |e VerfasserIn  |0 (DE-588)1078351791  |0 (DE-627)838359760  |0 (DE-576)184847508  |4 aut 
700 1 |a Lemmer, Björn  |d 1942-  |e VerfasserIn  |0 (DE-588)10728605X  |0 (DE-627)623794632  |0 (DE-576)32156345X  |4 aut 
773 0 8 |i Enthalten in  |t Journal of cardiovascular pharmacology  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1979  |g 41(2003), 6, Seite 890-896  |h Online-Ressource  |w (DE-627)330612824  |w (DE-600)2049700-3  |w (DE-576)094752877  |x 1533-4023  |7 nnas  |a Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats 
773 1 8 |g volume:41  |g year:2003  |g number:6  |g pages:890-896  |g extent:7  |a Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats 
856 4 0 |u https://doi.org/10.1097/00005344-200306000-00009  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.lww.com/cardiovascularpharm/Fulltext/2003/06000/Effects_of_the_Endothelin_A_Receptor_Antagonist.9.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220328 
993 |a Article 
994 |a 2003 
998 |g 10728605X  |a Lemmer, Björn  |m 10728605X:Lemmer, Björn  |d 60000  |d 65400  |d 60000  |e 60000PL10728605X  |e 65400PL10728605X  |e 60000PL10728605X  |k 0/60000/  |k 1/60000/65400/  |k 0/60000/  |p 6  |y j 
998 |g 1078351791  |a Kirchengast, Michael  |m 1078351791:Kirchengast, Michael  |d 60000  |e 60000PK1078351791  |k 0/60000/  |p 5 
998 |g 1028374690  |a Schilling, Lothar  |m 1028374690:Schilling, Lothar  |d 60000  |d 62600  |e 60000PS1028374690  |e 62600PS1028374690  |k 0/60000/  |k 1/60000/62600/  |p 4 
998 |g 1104517922  |a Witte, Klaus  |m 1104517922:Witte, Klaus  |d 60000  |d 65400  |d 60000  |e 60000PW1104517922  |e 65400PW1104517922  |e 60000PW1104517922  |k 0/60000/  |k 1/60000/65400/  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1796774545  |e 4104187453 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Klaus Witte, Ina Reitenbach, Kerstin Stolpe, Lothar Schilling, Michael Kirchengast, and Björn Lemmer"]},"id":{"eki":["1796774545"],"doi":["10.1097/00005344-200306000-00009"]},"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"June 2003"}],"relHost":[{"origin":[{"dateIssuedKey":"1979","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1979-","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]"}],"id":{"issn":["1533-4023"],"eki":["330612824"],"zdb":["2049700-3"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of cardiovascular pharmacology","title_sort":"Journal of cardiovascular pharmacology"}],"pubHistory":["1.1979 -"],"part":{"year":"2003","issue":"6","pages":"890-896","text":"41(2003), 6, Seite 890-896","volume":"41","extent":"7"},"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 24. November 2020"],"disp":"Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki ratsJournal of cardiovascular pharmacology","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"330612824"}],"physDesc":[{"extent":"7 S."}],"person":[{"display":"Witte, Klaus","roleDisplay":"VerfasserIn","role":"aut","family":"Witte","given":"Klaus"},{"family":"Reitenbach","given":"Ina","display":"Reitenbach, Ina","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Stolpe, Kerstin","roleDisplay":"VerfasserIn","given":"Kerstin","family":"Stolpe"},{"family":"Schilling","given":"Lothar","roleDisplay":"VerfasserIn","display":"Schilling, Lothar","role":"aut"},{"role":"aut","display":"Kirchengast, Michael","roleDisplay":"VerfasserIn","given":"Michael","family":"Kirchengast"},{"given":"Björn","family":"Lemmer","role":"aut","display":"Lemmer, Björn","roleDisplay":"VerfasserIn"}],"title":[{"title_sort":"Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats","title":"Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats"}],"recId":"1796774545","language":["eng"],"note":["Gesehen am 28.03.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a WITTEKLAUSEFFECTSOFT2003